Persistence of Human Immunodeficiency Virus-1 Drug Resistance Mutations in Proviral Deoxyribonucleic Acid After Virologic Failure of Efavirenz-Containing Antiretroviral Regimens

BACKGROUND: Efavirenz (EFV)-based regimens select broad drug resistance to nonnucleoside reverse-transcriptase inhibitors (NNRTIs), limiting the effectiveness of EFV and other NNRTIs. The duration, persistence, and decay of drug resistance mutations (DRMs) in the proviral reservoir is not well defin...

Descripción completa

Detalles Bibliográficos
Autores principales: De La Cruz, Justin, Vardhanbhuti, Saran, Sahoo, Malaya K, Rovner, Robert, Bosch, Ronald J, Manasa, Justen, Katzenstein, David A, Pinsky, Benjamin A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405934/
https://www.ncbi.nlm.nih.gov/pubmed/30863788
http://dx.doi.org/10.1093/ofid/ofz034

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405934/
https://www.ncbi.nlm.nih.gov/pubmed/30863788
http://dx.doi.org/10.1093/ofid/ofz034

Ejemplares similares